ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation.

J. Lee,1 D. Kim,1 J. Lee,1 S.-K. Kwon,1 S. Song,1 J. Lee,1 B. Kim,2 M. Kim,1 S. Kim,1 Y. Kim,1 K. Huh.1

1Transplantation Surgery, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea
2Nephrology, Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea

Meeting: 2017 American Transplant Congress

Abstract number: B72

Keywords: Antibodies, Gene polymorphism, Kidney transplantation, Rejection

Session Information

Session Name: Poster Session B: Antibody Mediated Rejection in Kidney Transplant Recipients II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Antibody-mediated rejection (AMR) is the leading cause of graft failure after kidney transplantation. C-C Chemokine receptor 5 (CCR5) plays an important role in immune cell migration and cytokine release. The CCR5 deficient mice have been implicated in experimental model for AMR. The aim of this study is to investigate the influence of genetic variation of CCR5 in susceptibility to AMR after kidney transplantation

We analyzed 190 recipients who underwent kidney transplantation without pre-transplant donor specific antibodies between May 2013 and December 2014. We investigated a CCR5 promoter polymorphism, -2459 A>G (rs1799987), that has been shown to affect expression of the CCR5 receptor. Genetic polymorphism was detected by the TaqMan assay.

AMR occurred in 20 patients (10.5%) of 190 kidney transplant recipients within 1 year. The incidences of AMR for AA genotype, AG genotype, and GG genotype were 25% (11/44), 7.1% (7/98), and 4.2% (2/48), respectively (p=0.001). The recipient AA genotype of CCR5 -2459 A>G (rs1799987) was associated with increased risk for AMR after adjusting for covariates such as ABO incompatibility, human leukocyte antigen mismatch, and panel reactive antibodies (OR, 7.123; 95% CI, 1.411-35.967; p=0.017).

The CCR5 -2459 (rs1799987) AA genotype of recipient was an independent risk factor for AMR after kidney transplantation.

CITATION INFORMATION: Lee J, Kim D, Lee J, Kwon S.-K, Song S, Lee J, Kim B, Kim M, Kim S, Kim Y, Huh K. C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Lee J, Kim D, Lee J, Kwon S-K, Song S, Lee J, Kim B, Kim M, Kim S, Kim Y, Huh K. C-C Chemokine Receptor 5 Polymorphisms and Risk of Antibody-Mediated Rejection in Renal Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/c-c-chemokine-receptor-5-polymorphisms-and-risk-of-antibody-mediated-rejection-in-renal-transplantation/. Accessed June 3, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences